Professor Jean Abraham
Professor in Precision Breast Cancer Medicine, Director of the Precision Breast Cancer Institute, Subject Director for the Part IB Biology of Disease course
Research interestsResearch Interests
Developing innovative clinical trials in high risk and hereditary early-stage breast cancers, and using multi-modal data integration to develop predictive and prognostic tools to provide individualised treatment strategies for breast cancer patients to improve clinical outcomes.
She is Chief Investigator of eight national/regional trials. This includes the Personalised Breast Cancer Programme, which delivers real-time whole genome and whole transcriptome sequencing for clinical actionability. She is a member of the NIHR Clinical Studies Group for Breast Cancer, which sets the national clinical trials research strategy and she chairs the Genomics Working Group. Jean has also advised the National Institute for Health and Care Excellence on breast cancer therapeutics and provides expert witness for the House of Commons Select Committee on Genomics and Gene Editing.
Developing innovative clinical trials in high risk and hereditary early-stage breast cancers, and using multi-modal data integration to develop predictive and prognostic tools to provide individualised treatment strategies for breast cancer patients to improve clinical outcomes.
She is Chief Investigator of eight national/regional trials. This includes the Personalised Breast Cancer Programme, which delivers real-time whole genome and whole transcriptome sequencing for clinical actionability. She is a member of the NIHR Clinical Studies Group for Breast Cancer, which sets the national clinical trials research strategy and she chairs the Genomics Working Group. Jean has also advised the National Institute for Health and Care Excellence on breast cancer therapeutics and provides expert witness for the House of Commons Select Committee on Genomics and Gene Editing.